# Allevion Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allevion-therapeutics

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.alleviontx.com
- Latest round: Seed (May 9, 2018)
- Investors on record: 1

## About

Based in California, US, and founded in 2017 and led by CEO Shawn Moaddeb, Allevion Therapeutics, Inc. operates as a healthcare company that develops smart wearable device that minimizes hand and leg tremor and other movement-related disorders such as Parkinson's disease and Dystonia. In March 2024, Allevion Therapeutics, Inc. raised an amount of USD 1.48 million in Series A. 

Allevion Therapeutics, Inc. developed the product known as the Allevx, which is a wrist-wearable neuromodulation device designed to reduce hand tremors through a combination of low-frequency ultrasound and electrical stimulation. The company’s device offers patients a discreet, customizable, and non-invasive treatment option with its smart energy modulation algorithms, cloud-based remote monitoring, and low power consumption, the Allevx Smart-Band provides a significant competitive advantage over traditional physical aids, pharmacological treatments, and surgical interventions.

## Funding rounds

- Seed, May 9, 2018 — Adventus Ventures

## Investors

- Adventus Ventures (https://capitalatlas.ai/funds/adventus-ventures) — Seed